Lei Hu
-
- Thyroid Cancer Diagnosis and Treatment 8
-
- Radiomics and Machine Learning in Medical Imaging 5
- Ultrasound Imaging and Elastography 3
-
- Head and Neck Anomalies 3
- Salivary Gland Tumors Diagnosis and Treatment 3
-
- Chronic Lymphocytic Leukemia Research 2
-
- Biomarkers in Disease Mechanisms 2
-
- Pharmacogenetics and Drug Metabolism 2
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Endocrinology (1 paper)Pharmaceutical Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lei Hu
32 papers receiving 300 citations
Peers
Comparison fields: 5 of 84
- Endocrinology, Diabetes and Metabolism 72
- Cancer Research 57
- Transplantation 7
- Periodontics 11
- Radiology, Nuclear Medicine and Imaging 52
Countries citing papers authored by Lei Hu
This map shows the geographic impact of Lei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Hu more than expected).
Fields of papers citing papers by Lei Hu
This network shows the impact of papers produced by Lei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Hu. The network helps show where Lei Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 11 | |
| 15 | 2020 | 18 | |
| 16 | 2019 | 14 | |
| 17 | 2019 | 6 | |
| 18 | 2018 | 32 | |
| 19 | Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes. | 2017 | 13 |
| 20 | 2012 | 7 |
About Lei Hu
Lei Hu is a scholar working on Endocrinology, Diabetes and Metabolism, Complementary and Manual Therapy and Transplantation, having authored 35 papers that have together received 306 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Head and Neck Anomalies (3 papers), Ultrasound Imaging and Elastography (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Biomarkers in Disease Mechanisms (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (72 citations), Cancer Research (57 citations) and Transplantation (7 citations). Lei Hu has collaborated with scholars based in China and United States. Frequent co-authors include Nianan He, Fang Zou, Zhiqiang Zhu, Xiao Wan, Huo Wu, Shaojun Liu, Wenxiong Zhang, Li Wu, Liu Liu and Yi‐Ren He. Their work appears in journals such as Biochemical and Biophysical Research Communications, Endocrinology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.